GlaxoSmithKline: all 4,196 studies
Page 27 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of GSK2256294 in Healthy Volunteers, and Single and Repeat Doses of GSK2256294 in Adult Male Moderately Obese SmokersCompletedNCT01762774Phase 1
- A Study to Evaluate the Effect of Losmapimod on Cardiac Conduction as Compared to Placebo and MoxifloxacinCompletedNCT01756495Phase 1
- A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy SubjectsCompletedNCT01756131Phase 1
- Bioequivalence Minocycline BioequivalenceCompletedNCT01755611Phase 1
- A Randomized Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult SubjectsCompletedNCT01754116Phase 1
- To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy VolunteersCompletedNCT01751074Phase 1
- A Study to Assess the Effect of SB 659032 on Platelet FunctionCompletedNCT01750827Phase 1
- Bioequivalence Study of Nimesulide 100 mg TabletsCompletedNCT01745614Phase 1
- Bioequivalence Study of Escitalopram Tablets 10 mgCompletedNCT01745601Phase 1
- Bioequivalence Trial of Alprazolam 2 mg TabletsCompletedNCT01745575Phase 1
- Bioequivalence Trial of Alprazolam 0.5 mg TabletsCompletedNCT01745562Phase 1
- SB-659032 Platelet Aggregation StudyCompletedNCT01745458Phase 1
- Bioequivalence Study of 300 mg GabapentinCompletedNCT01738893Phase 1
- To Evaluate the Influence of the A118G Polymorphism in the mu Opioid Receptor Gene (OPRM1) on Effects of GSK1521498 and Naltrexone on Physiological and Behavioural Markers of Brain Function in Healthy Social DrinkersCompletedNCT01738867Phase 1
- Safety Study of Measles-Mumps-Rubella-Varicella (MMRV) Vaccine, Priorix-Tetra™ in Children Living in the PhilippinesWithdrawnNCT01738841
- A Study to Evaluate the Effect of Repeat Oral Dosing of GSK2118436 on Cardiac Repolarization in Subjects With V600 BRAF Mutation-Positive TumorsCompletedNCT01738451Phase 1
- Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus GastroenteritisCompletedNCT01733862
- A Study to Estimate the Occurrence of Rotavirus Gastroenteritis in Children < 5 Years of Age, in Bulgaria and LatviaCompletedNCT01733849
- Neisseria Meningitidis Burden of Disease StudyCompletedNCT01730391
- To Investigate the Pharmacokinetics and Safety of Fluticasone Furoate (FF)/ Umeclidinium (UMEC) Combination Compared With FF and UMEC Monotherapies in Adult Healthy Volunteers Using a Dry Powder Inhaler (DPI)CompletedNCT01725685Phase 1
- Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Extended Release Metformin and Extended Release Glimepiride in Health VolunteersTerminatedNCT01725672Phase 1
- A Proof of Mechanism Study With GSK2126458 in Patients With Idiopathic Pulmonary Fibrosis (IPF)CompletedNCT01725139Phase 1
- A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor MalignanciesCompletedNCT01725100Phase 1
- Trobalt™ Products Risk SurveyCompletedNCT01721213
- A Study to Evaluate the Effect of Two Different Repeat Doses of GSK2190915 on the QTc Interval.WithdrawnNCT01721135Phase 1
- Assess the Risk of Solid Organ Transplant Rejection Following Vaccination With Pandemrix™ in UKCompletedNCT01715792
- Rosuvastatin Calcium Bioequivalence Study - FastCompletedNCT01711749Phase 1
- A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal ImpairmentCompletedNCT01711723Phase 1
- Relovair PD PK in Chinese Healthy SubjectsCompletedNCT01711463Phase 1
- BE STUDY OF METFORMIN GSK 1000mgCompletedNCT01710553Phase 2
- BE Study of Metformin GSK 850mgCompletedNCT01710540Phase 2
- This Study Will Investigate the Safety, Tolerability and Pharmacokinetic Profile of Repeat Oral Doses of GSK2140944 in Healthy Adult SubjectsCompletedNCT01706315Phase 1
- Burden of Respiratory Syncytial Virus (RSV) in the United Kingdom From 1995 to 2009CompletedNCT01706302
- Sero-prevalence of Anti-pertussis Antibodies and Disease Awareness Among Spanish Healthcare ProfessionalsCompletedNCT01706224
- Incidence of Expression of Tumor Antigens in Cancer Tissue From Patients With Pathologically Demonstrated Bladder CancerCompletedNCT01706185
- A Study to Assess the Relative Bioavailability of New Oral Formulations of SRT2104 in Healthy Male VolunteersCompletedNCT01702493Phase 1
- Effects of Triglycerides on Age-Related Cognitive Function Decline in Older SubjectsCompletedNCT01702480Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy VolunteersCompletedNCT01702467Phase 1
- This Study Will Investigate the Effect of Single Oral Doses of Retosiban on Cardiac Repolarization, With Moxifloxacin as a Positive Control in Healthy Volunteers.CompletedNCT01702376Phase 1
- A Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase StudyTerminatedNCT01702350Phase 1
- Prevalence-based Health and Economic Model of the Bivalent Versus the Quadrivalent Human Papillomavirus (HPV) VaccineCompletedNCT01702337
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2849466 in Healthy Male SubjectsCompletedNCT01696604Phase 1
- Pharmacokinetic Study of Retigabine Extended Release (XR) Formulation in Healthy Adult Japanese and Caucasian SubjectsWithdrawnNCT01691872Phase 1
- A Study to Assess the Systemic Exposure, Systemic Pharmacodynamics and Safety and Tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol in Healthy SubjectsCompletedNCT01691547Phase 1
- ARIXTRA® Adherence in SVT Patients.CompletedNCT01691495
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and GenderCompletedNCT01687309Phase 1
- Study to Analyze the Clinical and Cost Impact of Complete and Incomplete Rotavirus (RV) VaccinationCompletedNCT01682005
- WEUSRTP4850: Phase II: ICS/LABA Use in Pregnancy and OutcomesCompletedNCT01681979
- A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former SmokersCompletedNCT01678677Phase 1
- Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy VolunteersCompletedNCT01673555Phase 1
- Investigation of Topical SB705498 on Healthy VolunteersCompletedNCT01673529Phase 1
- Study to Evaluate the Pharmacokinetics, Safety and Tolerability of GSK557296 in Healthy Women Volunteers After Single and Repeat DosingCompletedNCT01669083Phase 1
- A Four-way Crossover, Single and Repeat Dose Study to Determine the Dose Proportionality and Absolute Bioavailability of Fluticasone Furoate Inhalation Powder Administered by Novel Dry Powder Inhaler (NDPI)CompletedNCT01669070Phase 1
- A Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C -GSK1322322 After an Intravenous and an Oral DoseCompletedNCT01663389Phase 1
- Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Influenza Vaccines GSK2654911A and GSK2654909A Administered to Adults 18 to 64 Years of AgeCompletedNCT01659086Phase 1
- A Study to Investigate the Efficacy and Safety of GSK1605786 for Treatment of Patients With Active Ulcerative ColitisWithdrawnNCT01658605Phase 2
- A Study to Look at the Electrical Activity of the Heart in Subjects With Solid Tumor Cancers, Before and After Receiving the Study Treatment, GSK1120212CompletedNCT01658553Phase 1
- WEUSKOP6166: Lamotrigine and Aseptic MeningitisCompletedNCT01657864
- Bioequivalence - Duodart Against Avodart & OmnicCompletedNCT01657851Phase 1
- Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult SubjectsCompletedNCT01657552Phase 1
- Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) VaccineCompletedNCT01657526Phase 1
- Aura Adolescent PK Study GSK2829332WithdrawnNCT01653483Phase 2
- Assessment of the Serologic Response to Porcine Circovirus Type 1 (PCV-1) in the Serum of Infants and Toddlers, Following Administration of IPV (Inactivated Poliovirus Vaccine)-Containing VaccinesCompletedNCT01651247
- Relative Bioavailability Study of GSK1265744 FormulationsCompletedNCT01648257Phase 1
- Crossover Study to Evaluate the Comparative Bioavailability of Two Fixed Dose Combination Tablet Formulations of Amlodipine and Losartan in Health VolunteersCompletedNCT01648231Phase 1
- Phase I Study of GW856553 (Losmapimod)CompletedNCT01648192Phase 1
- A Study to Assess the Relative Bioavailability of Three Formulations and Food Effect on GSK1322322 in Healthy SubjectsCompletedNCT01648179Phase 1
- Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DMCompletedNCT01648153Phase 2
- Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) FormulationCompletedNCT01647659Phase 1
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy VolunteersCompletedNCT01640990Phase 1
- Special Drug Use Investigation for ROTARIX®CompletedNCT01636739
- WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial InfarctionCompletedNCT01636726
- SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033)CompletedNCT01636271
- Drug Use Investigation for ROTARIX®CompletedNCT01636193
- A Two Cohort Study to Look at the Metabolites of GSK221149, the Metabolism of GSK221149 Administered With a High Fat Meal and With KetoconazoleCompletedNCT01627587Phase 1
- Evaluation of the Bioequivalence of a Combined Formulated TabletCompletedNCT01622790Phase 1
- Pharmacokinetic Study of Levocetirizine Oral SolutionCompletedNCT01622283Phase 1
- WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins)CompletedNCT01616472
- Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Repeat IV DosesCompletedNCT01615796Phase 1
- Clinical and Economic Burden of Patients With Chronic Obstructive Pulmonary Disease in a Medicaid PopulationCompletedNCT01615783
- Japanese Phase I of GSK1605786CompletedNCT01611805Phase 1
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Oral and Intravenous GSK1322322 in Healthy SubjectsCompletedNCT01610388Phase 1
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetic a Single Day of Dosing With GSK1614235.CompletedNCT01607385Phase 1
- A Study to Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory AllergiesCompletedNCT01607372Phase 2
- WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & SuicideCompletedNCT01607333
- Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With PlaceboCompletedNCT01607086Phase 1
- A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid MalignanciesSuspendedNCT01604863Phase 1
- Type II Diabetes Mellitus in Patients Exposed to Pravastatin and ParoxetineCompletedNCT01602913
- Healthy Volunteer Positron Emission Tomography (PET) Brain Occupancy Study of a Phosphodiesterase 4 (PDE4) Inhibitor in Huntington's DiseaseCompletedNCT01602900Phase 1
- A Study to Test the Possibility of Cross Reaction Induced by the Idursulfase Drug to GSK2788723CompletedNCT01602601
- Influenza Burden Assessment in the United States, July1997 - up to April 2009CompletedNCT01599390
- Estimate the Effect of Telaprevir and Boceprevir on Maraviroc Pharmacokinetics in Healthy SubjectsCompletedNCT01597895Phase 1
- Acotral® Versus Zetia® Ezetimibe Bioequivalance Study.CompletedNCT01597700Phase 1
- Bupropion & Cardio Birth Defect (Slone)CompletedNCT01597661
- A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™CompletedNCT01597648Phase 1
- A Study to Characterise the Physiology of Weight Loss and Regain Under Dietary, Behavioural and Pharmacological Interventions in Healthy Obese SubjectsCompletedNCT01597609Phase 1
- A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult SubjectsCompletedNCT01593046Phase 1
- Impact on Quality of Hospital Care During Pre- and Post- Rotavirus (RV) Vaccination Introduction in BelgiumCompletedNCT01592838
- A Study to Compare Two Paracetamol Formulations.CompletedNCT01592227Phase 1
- WEUKBRE5559: IMI PROTECT: Benzodiazepines & FractureCompletedNCT01587833